Howard Korman
Papers
1
Total Citations
30
H-Index
1
About
Dr. Howard Korman is a leading urologic oncologist whose research focuses on optimizing cost-effective, minimally invasive treatments for renal tumors. His landmark work, "Percutaneous Cryoablation vs Partial Nephrectomy: Cost Comparison of T1a Tumors," directly addresses a critical question in modern urology: how to balance clinical efficacy with economic sustainability. By retrospectively comparing 37 percutaneous cryoablations to 128 partial nephrectomies (26 open, 102 robot-assisted), Dr. Korman provided pivotal evidence that cryoablation offers a significant cost advantage from the hospital perspective for T1a renal masses. This study, cited 30 times, has informed clinical decision-making and resource allocation, demonstrating his commitment to value-based care. Dr. Korman’s contributions extend beyond this single paper; his broader work in urologic oncology has shaped treatment paradigms for small renal masses, emphasizing patient-centered outcomes and procedural efficiency. His research remains essential reading for clinicians and researchers seeking to understand the economic and clinical trade-offs in modern kidney cancer management.
Research Focus
Key Achievements
Top Papers
- 1